What Larazotide is
Orally administered tight-junction modulator studied primarily in celiac disease and intestinal-barrier research. It is also referred to as Larazotide acetate and AT-1001.
How it works
Derived from zonula occludens toxin sequence; proposed to reduce paracellular permeability by modulating tight-junction signaling.
What the evidence shows
Multiple human trials have been conducted; it is not FDA-approved.
Evidence level: B/C — Human clinical evidence.
Routes studied: Oral.
Doses studied: Human clinical-trial doses are indication- and protocol-specific. There is no approved dose.
What this page does not claim
Larazotide is not a “leaky gut cure”.
Safety considerations
Trial safety has generally been acceptable, but efficacy has been inconsistent and development history should be accurately summarized.
- Cautions and contraindications: Trial/product-specific.
Sport and anti-doping
Unknown.
Availability at True Heal Wellness
True Heal Wellness does not offer, sell or administer Larazotide. This page exists as an educational reference only.